Ordering
Available Variants5 g
CHA.73521-5g
Price
€23.20
Available – Dispatch in 14 days
10 g
CHA.73521-10g
Price
€52.32
Available – Dispatch in 14 days
50 g
CHA.73521-50g
Price
€172.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHA.73521-5g | €23.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 g | CHA.73521-10g | €52.32 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 g | CHA.73521-50g | €172.80 |
synthetic, ≥90% (HPLC), Potassium channel blocker
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H24N2O2 · 0.5H2O4S · H2O |
|---|---|
| CAS Number | 207671-44-1 |
| Molecular Weight | 391.47 |
| NACRES | NA.77 |
| PubChem Substance ID | 57654578 |
| UNSPSC Code | 12352210 |
| MDL number | MFCD00150790 |
| Beilstein/REAXYS Number | 6113937 |
| Assay | ≥90% (HPLC) |
| Quality level | 200 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H315,H319,H335 |
| pcodes | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Gloves |
Technical Overview & Applications Use-case context
Quinine hemisulfate salt monohydrate, with a CAS number of 130-95-0, is a pharmaceutical compound utilized in the treatment of malaria and other diseases. This salt form of quinine is highly soluble in water, making it suitable for various medical applications. The monohydrate crystalline structure of quinine hemisulfate salt is stable and exhibits a high degree of purity, which is essential for its use in medicinal formulations. Quinine hemisulfate salt monohydrate is synthesized through a reaction between quinine and sulfuric acid, followed by crystallization to produce a highly pure compound. Its chemical properties and solubility make it an ideal intermediate for the production of quinine-based medications, which are used to treat a range of diseases, including malaria, and other conditions where quinines therapeutic properties are beneficial.
